Loblaw, a prominent grocery retailer, reported increased profits in the second quarter by attracting budget-conscious shoppers to its discount chains, No Frills and Maxi, the company announced recently. Sales growth was particularly robust in its pharmacy division, driven by the popularity of generic GLP-1 weight loss medications.
The Ontario-based company disclosed its financial performance for the three months ending on June 20, revealing revenue exceeding $15.3 billion, marking a four percent rise from the previous quarter. Profit available to common shareholders surged by approximately five percent to $751 million.
Loblaw noted a 1.6 percent increase in same-store sales for its core retail food segment, while its drug retail arm, including Shoppers Drug Mart, experienced a 4.6 percent rise in same-store sales, mainly fueled by a 7.5 percent growth in pharmacy and health-care services.
During a conference call with analysts, Chief Financial Officer Richard Dufresne highlighted the positive impact of the emerging generic GLP-1 drugs on the company’s pharmacy performance, anticipating higher revenue, gross profit, and gross margin rate despite lower generic drug pricing.
The GLP-1 drug category, encompassing brands like Ozemic and Wegovy, has seen a significant uptick in sales, up 40 percent year-to-date, following Health Canada’s approval of the country’s first generic semaglutide injection in April.
CEO Per Bank informed analysts that cost-conscious consumers are increasingly opting for frozen vegetables over fresh produce due to inflationary pressures, with a substantial 45.2 percent year-over-year surge in fresh tomato prices reported by Statistics Canada.
Loblaw executives emphasized that their No Frills and Maxi stores are strategically positioned to cater to value-seeking customers amid persistent food price inflation, allowing them to outperform competitors in both hard discount and conventional segments.
Despite fluctuations in the market, Loblaw’s Toronto-listed shares remained relatively stable on Thursday, reflecting a year-to-date gain of approximately six percent.
(Source: CBC News)